Optimization of renin-angiotensin-aldosterone inhibitor therapies for evidence-based indications: A call to action from the cardio-kidney community

2025/06/09 by Roberto Pecoits‐Filho, Roberto Pecoits-Filho, Michelle Wong +22 · 1 voice
Medicine · #Blood Pressure and Hypertension Studies #Heart Failure Treatment and Management #Potassium and Related Disorders

paper · doi:10.1016/j.ajpc.2024.100663

openalex publication_date 2025/06/09 · crossref created 2025/06/09 · crossref issued 2025/09/01 · crossref published 2025/09/01 · crossref published-print 2025/09/01 · openalex created_date 2025/10/10 · crossref deposited 2025/10/16 · crossref indexed 2026/03/06 · openalex updated_date 2026/07/22

Citations

• 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
• Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
• 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
• Kidney Function and Outcomes in Patients Hospitalized With Heart Failure
• Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials

Discussions

• Link in skeet was broken but found it here doi.org/10.1016/j.aj... [bsky, 0 points, 0 comments]